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PROTECTION OR RESECTION: BOD1L AS A NOVEL REPLICATION FORK 
PROTECTION FACTOR 
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UK 
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Stewart. BOD1L is required to suppress deleterious resection of stressed replication forks. 
Molecular Cell, 2015, 59(3):462-77. 
ABSTRACT 
Replication stress, defined as the slowing or stalling of cellular DNA replication forks, 
represents a serious threat to genome stability. Numerous cellular pathways protect against 
replication stress and maintain genomic integrity. Amongst these, the Fanconi 
Anemia/homologous recombination pathways are critical for recognising and repairing 
stalled replication forks. Members of these pathways play a vital role in protecting damaged 
forks from uncontrolled attack from cellular nucleases, which would otherwise render these 
irreparable. Recent studies have begun to shed light on the protective factors necessary to 
supress nucleolytic over-processing of nascent DNA, and on the different cellular nucleases 
involved. Here, we review our recent identification of a novel fork protection factor, BOD1L, 
and discuss its role in preventing the processing of stalled replication forks within the context 
of current knowledge of the replication fork ‘protectosome’. 
KEYWORDS 
BOD1L; Fanconi Anaemia; homologous recombination; RAD51; replication stress, nascent 
strand degradation. 
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REPLICATION STRESS AND FORK PROTECTION 
Perturbation of cellular DNA replication by both endogenous and exogenous factors 
leads to replication fork slowing, stalling and/or collapse, termed replication stress. An 
inability to deal with such replication stress contributes to the development of human 
disease.1 Notably, unresolved replication stress leads to genomic instability, a frequent 
hallmark of tumours. A plethora of cellular proteins are involved in the cellular response to 
replication stress. Since these components are vital in maintaining genome stability, they 
therefore represent critical obstacles to the initiation/progression of cellular transformation. 
Over the past decade, much progress has been made in understanding the function 
of proteins involved in the replication stress response. These studies have underlined a 
crucial role for proteins involved in the Fanconi Anaemia (FA)/homologous recombination 
(HR) pathway in maintaining genome stability upon replication damage. Components of this 
pathway have classically been associated with the HR-dependent repair of inter-strand 
crosslinks (ICLs), and mutations in these genes give rise to Fanconi Anaemia, a rare 
disorder characterized by severe developmental abnormalities, bone marrow failure, tumour 
predisposition and a hypersensitivity to agents that induce ICLs, such as mitomycin C 
(MMC) and cisplatin (for a review see2). To date, mutations in 18 different genes (designated 
as complementation groups FANCA-T) have been identified in FA patients.3, 4 
In addition to their importance in promoting the repair of ICLs, it is now apparent that 
several FA/HR proteins also play a role in protecting stalled/collapsed replication forks from 
uncontrolled nucleolysis. If left unprotected, excessive nucleolytic processing renders such 
forks unrecoverable, and may perturb replication to such an extent that stretches of under-
replicated DNA accumulate, particularly around common fragile sites (CFS), which ultimately 
manifests as severe chromosome damage. Furthermore, loss of fork protection may also 
lead to inappropriate repair of the stalled/collapsed replication fork by alternative pathways 
such as non-homologous end-joining (NHEJ), resulting in chromosomal fusions or 
translocations. These fork protection factors therefore represent important barriers to 
prevent genome instability (Figure 1). 
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FORK PROTECTION FACTORS 
Several FA/HR proteins are involved in suppressing replication fork over-processing 
by cellular nucleases.5-11 It seems that the DNA recombinase RAD51 is crucial for fork 
protection, and defects in RAD51-mediated fork protection underlie the uncontrolled fork 
resection observed in the absence of many components of the FA/HR pathway. The most 
well-characterised function of RAD51 is its ability to promote strand exchange during HR, by 
displacing the single-stranded DNA binding protein RPA to form helical nucleofilaments. 
These filaments search for homologous sequences and catalyse strand invasion prior to the 
initiation of repair DNA synthesis and resolution of the joined molecules (for a review, see 
ref12). However, more recently it has been shown that the loading of RAD51 at replication 
forks also functions to stabilise replication fork intermediates and prevent deleterious 
nucleolytic over-processing.5, 6, 13 Moreover, it seems that this protective function of RAD51 
is similarly dependent on its ability to form nucleofilaments at replication forks.5, 6 
In addition to RAD51, the FA proteins FANCA, FANCB, FANCD2, PALB2 (FANCN), BRCA1 
(FANCS) and BRCA2 (FANCD1) also suppress genomic instability upon replication fork 
stalling, by preventing the degradation of nascent DNA.6, 11, 14 Since BRCA1, PALB2 and 
BRCA2 are required to load RAD51 onto ssDNA at stalled replication forks, it is natural to 
assume that their ability to protect replication forks from degradation is due to their role in 
this process. However, studies of a BRCA2 mutant that lacks a conserved C-terminal 
RAD51-binding site revealed that this region is essential for fork protection but dispensable 
for loading RAD51 onto DNA, and for HR.5 Therefore, subsequent to its loading, the 
stabilization of RAD51 at replication forks by BRCA2 is crucial in preventing excessive 
nucleolytic processing. Indeed, the stabilization of RAD51 nucleofilaments on ssDNA by 
preventing its ATP-dependent dissociation protects against the over-processing of forks 
when BRCA2 is missing. In analogous fashion, the helicase/nuclease WRN is thought to 
protect nascent DNA by stabilizing RAD51 nucleofilaments, through a mechanism 
independent of its enzymatic activity.7, 8 Similarly, the TLS polymerase REV1 has recently 
been reported to prevent fork resection, again through its ability to promote RAD51 foci 
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formation.9 Interestingly, PARP has also been implicated in facilitating RAD51-mediated 
protection of stalled replication forks10, although it is unclear whether this is mediated 
through the poly-ADP ribose (PAR) chain-dependent recruitment of protective factors to 
stalled forks or via an alternative mechanism. 
As mentioned above, FANCD2 stabilises and protect damaged forks from promiscuous 
nucleolytic attack.6, 15 However, deficiencies in FANCD2 do not lead to defects in the 
recruitment/stabilisation of RAD51 to stalled forks16, 17; this suggests that an inability to 
load/stabilise RAD51 may not account for all instances of fork instability. In addition, 
although depletion of the FA core factors FANCA and FANCB also causes increased fork 
processing, it is unclear whether this is due to a subsequent failure to promote FANCD2 
mono-ubiquitylation/relocalisation18, or via another mechanism. 
It is plausible that, in certain contexts, RAD51 filament dissolution may also be 
crucial in maintaining replication fork stability. The RECQL5 helicase acts to suppress HR 
via the dissolution of RAD51 nucleofilaments.19 Intriguingly, loss of RECQL5 alone leads to 
replication fork degradation, which is exacerbated by the loss of the FA pathway.11 
Therefore, it seems that both the de-stabilisation and over-stabilisation of RAD51 
nucleofilaments are deleterious to replication fork integrity. Moreover, since RECQL5 has 
been linked to the regulation of transcriptional stress20, it is tempting to speculate that the 
role of RAD51 at replication forks may differ between different genomic contexts e.g. 
replication forks that have stalled due to DNA lesions versus those that have stalled upon 
collision with transcription bubbles. Importantly, the protective function of many of the 
proteins described in this section is likely distinct from their role in promoting HR-mediated 
repair of double-strand breaks (DSBs). 
CELLULAR NUCLEASES INVOLVED IN FORK DEGRADATION 
Whilst it is clear that uncontrolled nucleolytic activity is clearly detrimental to genome 
stability7, 8, 21-24, a certain degree of regulated processing by these nucleases is necessary to 
allow the repair/restart of damaged replication forks. Years of study have implicated the 
nucleases MRE11, CtIP, DNA2, and EXO1 in the nucleolytic processing of DSBs, and have 
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uncovered complex mechanisms regulating DNA end resection. It is thought that MRE11 
and CtIP act together to perform short-range resection, whilst EXO1 and DNA2/BLM act 
independently to execute 5’-3’ long-range processing to facilitate RAD51 loading and strand 
invasion.25 
Unrestricted nucleolytic processing by these proteins also underlies excessive fork 
resection. MRE11 has been implicated in the uncontrolled resection observed in the 
absence of a many factors, including a functional FA/HR pathway: inhibition of MRE11 in the 
absence of FANCA, FANCB, BRCA1, BRCA2, FANCD2, RECQL5, REV1 and PARP1 
prevents fork resection.5, 6, 9, 11, 15 Moreover, MRE11-dependent fork resection underlies the 
increased chromosome breakage exhibited by BRCA2 null cells.5 Thus it seems that these 
FA/HR factors specifically restrict the activity of MRE11 at replication forks to prevent over-
processing. However, many of these studies (including our own) have made use of the 
MRE11 inhibitor Mirin. Therefore, it is conceivable that this inhibitor targets other cellular 
nucleases in a non-specific fashion, thus masking their importance in replication fork 
processing. 
In addition to MRE11, DNA2 and EXO1 also play important roles in fork processing. 
DNA2 knockdown, but not depletion of EXO1 or MRE11, has been shown to alleviate fork 
processing after hydroxyurea.26 Furthermore, RNAi-mediated depletion of DNA2 in 
FANCD2-deficient cells rescues their hypersensitivity to ICLs.24 Finally, EXO1 has also been 
directly implicated in fork over-resection: EXO1 knockdown reduced fork over-processing in 
WRN exonuclease mutant cells.7 In addition, yeast Exo1 is recruited to stalled forks where it 
mediates resection of newly synthesized DNA.27 It therefore seems that different fork 
protection factors act to antagonize the actions of specific nucleases. 
BOD1L PROTECTS REPLICATION FORKS FROM DNA2-DEPENDENT RESECTION 
Recently, we described the identification of a novel fork protection factor, BOD1L, 
which associates with the replication machinery.28 BOD1L-depleted cells exhibit increased 
degradation of stalled/damaged forks in a manner comparable to FANCD2/BRCA1/BRCA2 
deficient cells.6 Furthermore, BOD1L-deficient cells were defective in their ability to form 
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RAD51 foci at stalled forks, similar to cells lacking BRCA1/BRCA2/PALB2.29-31 However, 
further analysis revealed that this was not due to an inability to load RAD51 at these sites; 
instead, BOD1L was required to stabilize RAD51 by preventing the anti-recombinase 
activities of the RECQ-like helicases BLM and FBH1. Down-regulation of either BLM or 
FBH1 suppressed both the aberrant fork processing and the genomic instability observed in 
BOD1L-deficient cells, presumably due to their ability to suppress RAD51-mediated HR by 
disassembling RAD51 nucleofilaments.32-34 In this regard, BOD1L can be considered to 
function in an analogous manner to the C-terminus of BRCA2 i.e. by promoting RAD51 
nucleofilament stability.5, 35 However, despite our observations that loss of BLM/FBH1 could 
not restore the loading of RAD51 in BRCA2 deficient cells, it is unclear whether these 
helicases also play a role in antagonizing BRCA2-dependent RAD51 stabilisation. 
Given that MRE11-dependent resection underlies many aspects of excessive fork 
processing, we hypothesized that MRE11 may also be responsible for fork resection 
observed in the absence of BOD1L. Surprisingly, inhibition of MRE11 had no impact on 
nucleolytic fork processing in BOD1L-depeleted cells: instead, blocking DNA2-dependent 
resection restored normal fork resection and restored genome stability in the absence of 
BOD1L. This further supports the idea that different fork protection factors act to protect 
replication forks from individual nucleases (Figure 2). In light of this, loss of two 
independently acting fork protection factors would be expected to further increase fork 
resection. However, although BOD1L and BRCA2 suppress the actions of different 
nucleases at stalled forks (namely DNA2 and MRE11 respectively), we observed an 
epistatic relationship. Currently, the underlying reason for this is unclear. However, we 
hypothesise that nucleolysis of a damaged fork by one nuclease may prevent further 
nucleolytic processing by another. 
Together, our data suggests that the inability of BOD1L-deficient cells to stabilize 
RAD51 at stalled replication forks allows uncontrolled DNA2-dependent degradation of 
damaged forks. This is the first report of a fork protection factor that specifically acts to 
suppress DNA2-dependent processing of damaged replication forks. 
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A MULTI-PROTEIN FORK PROTECTION ‘PROTECTOSOME’ COMPLEX? 
One intriguing finding from our studies is that BOD1L co-immunoprecipitates with at 
least two known fork protection factors: BRCA2 and FANCD2.28 Moreover, unpublished data 
suggests that BOD1L may also interact with BRCA1. In addition, BOD1L loss is epistatic 
with depletion of BRCA1, BRCA2 and FANCA. We therefore suggest that a single complex 
containing multiple replication fork protection factors may exist. In support of this, several 
interactions between fork protection factors have been already reported in the literature, 
including between BRCA1, BRCA2, RAD51, FANCD2 and FANCA.36 Alternatively, it may be 
that smaller sub-complexes of these proteins act in a lesion-specific or context-specific 
manner to counter specific nucleases. It is also possible that these proteins may be 
temporally regulated to prevent nucleolytic processing at different stages of replication fork 
repair/restart, by countering ‘early’ MRE11-dependent or ‘late’ DNA2/EXO1-mediated 
resection. 
THE PHYSIOLOGICAL ROLE OF FORK PROTECTION 
Given the importance of replication fork protection in maintaining genome stability, 
this pathway likely plays a vital physiological role outside the laboratory. Firstly, during 
oncogene-induced replication stress, fork protection factors would be crucial to prevent 
chromosomal aberrations, which would otherwise promote cellular transformation. Since 
most fork protection factors also promote DNA replication and/or HR repair, which are 
important tumour suppressor functions, it is difficult to assess the impact of fork protection 
on tumourigenesis directly. Nevertheless, mutations affecting a CDK phosphorylation site in 
the C-terminus of BRCA2 that is important for regulating fork protection (but not HR) are 
found in individuals affected with breast cancer5, 37, suggesting fork degradation-dependent, 
HR-independent mechanisms may contribute to tumorigenesis. 
Secondly, it is likely that the presence and function of these protective proteins likely 
influences an individual’s response to chemotherapeutic treatment, particularly in response 
to agents (such as Hydroxyurea or Gemcitabine) that induce high levels of exogenous 
replication stress. In this instance, loss of fork protection likely contributes to tumour 
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progression by permitting wide-ranging genomic rearrangements. Moreover, in cells lacking 
these components, transient treatment with chemotherapeutics that induce replication stress 
would likely induce further mutagenesis and genome instability. 
Lastly, given that defects in replication stress response genes gives rise to 
developmental abnormalities and microcephaly1, it is likely that loss of the fork protection 
function of the encoded gene products contributes to the development of some of these 
clinical defects. 
CONCLUDING REMARKS AND FUTURE PERSPECTIVES 
The cellular response to replication stress is integral to maintaining genome stability, and 
defects in proteins which deal with replication stress are frequently associated with 
increased genome stability.1 Cellular components that protect against RS therefore act as 
anti-tumour barriers that must be surpassed/subverted before a tumour can develop. In 
particular, in the absence of these protective factors, unprotected replication forks are an 
important source of genomic instability, and in part underlie the severe chromosomal 
instability associated with loss of FA/HR components such as FANCD2, BRCA2 and 
BOD1L.6, 24, 28 
Although many fork protection factors have been identified, it is currently unclear how these 
factors suppress resection: they may interact with their partner nucleases directly, or may 
act indirectly to regulate nucleolysis through influencing the activity of anti-recombinases or 
by stabilising replication fork components. In addition, it is possible that more novel factors 
remain to be discovered. Elucidation of the mechanisms underlying fork protection 
represents an exciting future area of research, and may provide new therapeutic avenues for 
the treatment of diseases associated with an aberrant replication stress response. 
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Figure 1: The importance of fork protection in maintaining genome stability: i. Cellular 
replication forks can stall for a variety of reasons. In certain circumstances, stalled forks may reverse 
to aid repair or restart. ii. A variety of fork protection factors including RAD51 (described in the text) 
act to protect nascent DNA from over-processing by cellular nucleases (denoted by ‘pacman’ 
symbols). iii. This allows subsequent fork restart and/or repair by homologous recombination, and 
prevents genome instability. iv. In the absence of these protective factors, excessive nucleolytic 
processing of stalled/reversed forks leads to common fragile site and chromosomal instability, or to 
inappropriate repair giving rise to chromosomal fusions and radial chromosomes, ultimately leading to 
genomic instability (v). 
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Figure 2: The specificity of factors counteracting ‘fork’ nucleases: Three main cellular nucleases 
have thus far been implicated in the over-processing of stalled forks: MRE11, DNA2 and EXO1. There 
have been no reports that the nuclease CtIP is involved in over-processing of stalled replication forks. 
Several protective factors act on specific cellular nucleases to supress their aberrant activity on 
stalled replication forks (dotted red lines): several FA/HR proteins, the TLS polymerase REV1 and 
PARP1 have all been reported to inhibit MRE11-dependent fork resection, whilst the WRN 
helicase/nuclease prevents EXO1-dependent fork degradation. Recently, we demonstrated that 
BOD1L is required to supress DNA2-dependent strand degradation of stalled replication forks, 
alongside existing reports of a similar role for FANCD2. 
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